Thu, 19th Jul 2007 08:45 LONDON (Thomson Financial) - Futura Medical PLC said it remains confident of securing a licens
ing deal for its over-the-counter erectile dysfunction treatment, MED2002.
The pharmaceutical group, which develops innovative products for consumer healthcare, said the European Union approval of CSD500 remains on track for Q4, and the company is looking forward to making the transition to a revenue generating business with a recurring royalty stream.
In an AGM statement, chairman William Potter also said: 'We continue to make progress on our earlier-stage portfolio and in seeking new applications for our novel drug delivery technology, DermaSys'.
XX:SU:AFXSTORYML#SN:RNS4845A#XX:30678.0#HS:nitfwire_9250_2007-7-19_08:30:10_4_199#DU:nxafxw+borg+xfchk+lanafutxd1+lanafutxd2+nxtfew+lantfttxd2+lantfetxd2#XP:tfukfipm.datastream.com
~
TFN.newsdesk@thomson.com
ukn/ejp
COPYRIGHT
Copyright AFX News Limited 2007. All rights reserved.
The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.